Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Many skin patients also have mental health issues, and doctors should treat both together.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Women with PCOS have more emotional and body image issues than healthy women.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Better awareness of chemotherapy's side effects improves self-care.

People undergoing chemotherapy need better support and information to cope with hair loss.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Minoxidil and finasteride work best for hair loss; more research needed.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

PCOS in India is linked to broader sociocultural and environmental changes, not just diet and exercise.

M30 is a promising treatment for preventing hair loss during chemotherapy.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.